drugset / Trial / NCT00778518

Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).

NCT00778518 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

Study to find the optimal dose of Growth Hormone Replacement in young adult patients suffering from childhood onset growth hormone deficiency (GHD).

Timeline

Start
2008-07
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator ARX201 Unknown 2.5 mg —
Comparator ARX201 Unknown 5 mg —
Comparator ARX201 Unknown 10 mg —

Indications